^
Chr del(5q)
|
MDS
|
Chr del(5q)
|
MDS
|
lenalidomide Sensitive: A1 - Approval
|
lenalidomide Sensitive: A1 - Approval
|
Chr del(5q)
|
AML
|
Chr del(5q)
|
AML
|
venetoclax + ruxolitinib Resistant: C3 – Early Trials
|
venetoclax + ruxolitinib Resistant: C3 – Early Trials
|
